HEMODYNAMIC EFFECTS AND PLASMA CONCENTRATIONS OF LABETALOL DURING LONG-TERM TREATMENT OF ESSENTIAL HYPERTENSION

被引：43

作者：

LUNDJOHANSEN, P ^{[1
]}

BAKKE, OM ^{[1
]}

机构：

[1] UNIV BERGEN,SCH MED,CLIN PHARMACOL UNIT,CLIN BIOCHEM LAB,N-5014 BERGEN,NORWAY

来源：

关键词：

D O I：

10.1111/j.1365-2125.1979.tb00917.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

[No abstract available]

引用

页码：169 / 174

页数：6

共 18 条

[1] BOLLI P, 1976, BRIT J CLIN PHARMACO, V3, P765
[2] BRITTAIN RT, 1976, BRIT J CLIN PHARMACO, V3, P681
[3] DARGIE HJ, 1976, BRIT J CLIN PHARMACO, V3, P751
[4] EDWARDS RC, 1976, BRIT J CLIN PHARMACO, V3, P733
[5] JOEKES AM, 1976, BRIT J CLIN PHARMACO, V3, P789
[6] KANE J, 1976, BRIT J CLIN PHARMACO, V3, P737
[7] KOCH G, 1976, BRIT J CLIN PHARMACO, V3, P729
[8] KOCH G, 1976, BRIT J CLIN PHARMACO, V3, P725
[9] HEMODYNAMIC LONG-TERM EFFECTS OF A NEW BETA-ADRENOCEPTOR BLOCKING DRUG, ATENOLOL (ICI 66082), IN ESSENTIAL HYPERTENSION
LUNDJOHANSEN, P
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1976, 3 (03) : 445 - 451
[10] HEMODYNAMIC LONG-TERM EFFECTS OF PRAZOSIN PLUS TOLAMOLOL IN ESSENTIAL HYPERTENSION
LUNDJOHANSEN, P
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1977, 4 (02) : 141 - 145